Moskowitz Shaye I, Liu James, Krishnaney Ajit A
Department of Neurosurgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Neurosurgery. 2009 Mar;64(3 Suppl):ons28-33; discussion ons33-4. doi: 10.1227/01.NEU.0000334414.79963.59.
Dural replacements are used in cranial surgery when primary closure of native dura is not possible. The goal is to recreate a watertight barrier to prevent cerebrospinal fluid leakage with few associated complications. We reviewed a single-institution experience with a variety of dural substitutes in posterior fossa neurosurgery, for which higher complication rates are well described.
Patients were screened for suboccipital posterior fossa neurosurgery between November 2005 and April 2007. Surgical logs were reviewed for diagnosis, procedure, and use of dural replacement. Clinical courses were reviewed for hydrodynamic complications, including delayed hydrocephalus, clinically significant pseudomeningocele, aseptic meningitis, and persistent cerebrospinal leakage.
One hundred twenty-eight patients were included, and a dural replacement was used in 106. Overall, the complication rate was 21.9% (28 patients). Complications were seen for acellular human dermis in 33.3%, for collagen matrix in the original formulation in 18.2%, for the reformulation in 16.9%, for the suturable formulation in 50%, for nonautologous materials in 24%, and for no dural replacement in 16.7%. Univariate and multivariate analysis demonstrated that hydrodynamic complications were associated with use of the suturable collagen matrix (odds ratio, 10.8; 95% confidence interval, 2.5-46.1; P = 0.0014) and trended with use of acellular human dermis (odds ratio, 4.6; 95% confidence interval, 0.9-23.1; P = 0.06).
The increased risk of hydrodynamic complications associated with suboccipital neurosurgery is modified by choice of dural replacement. Similar complication rates were seen for most materials with a variety of primary abnormalities, with the exception of suturable bovine collagen matrix, with hydrodynamic complications in 50% of patients.
当无法对天然硬脑膜进行一期缝合时,硬脑膜替代物用于颅脑手术。目标是重建一个防水屏障以防止脑脊液漏出,同时减少相关并发症。我们回顾了一家机构在后颅窝神经外科手术中使用多种硬脑膜替代物的经验,后颅窝手术的并发症发生率较高已得到充分描述。
对2005年11月至2007年4月期间接受枕下后颅窝神经外科手术的患者进行筛查。查阅手术记录以了解诊断、手术过程及硬脑膜替代物的使用情况。回顾临床病程以了解流体动力学并发症,包括迟发性脑积水、具有临床意义的假性脑膜膨出、无菌性脑膜炎和持续性脑脊液漏。
共纳入128例患者,其中106例使用了硬脑膜替代物。总体并发症发生率为21.9%(28例患者)。脱细胞人真皮的并发症发生率为33.3%,原始配方胶原蛋白基质的并发症发生率为18.2%,改良配方的为16.9%,可缝合配方的为50%,非自体材料的为24%,未使用硬脑膜替代物的为16.7%。单因素和多因素分析表明,流体动力学并发症与使用可缝合胶原蛋白基质有关(比值比,10.8;95%置信区间,2.5 - 46.1;P = 0.0014),且使用脱细胞人真皮有相关趋势(比值比,4.6;95%置信区间,0.9 - 23.1;P = 0.06)。
通过选择硬脑膜替代物可改变枕下神经外科手术相关流体动力学并发症的增加风险。除可缝合牛胶原蛋白基质外,大多数材料在各种原发性异常情况下的并发症发生率相似,使用可缝合牛胶原蛋白基质的患者流体动力学并发症发生率为50%。